Anna K. Nurmi
Helsinki, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Recessive FANCM cancer syndrome with high cancer risks, chemotherapy toxicity, chromosome fragility, and gonadal failure.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: July 11, 2024
Cholangitis and Interruptions of Neoadjuvant Chemotherapy Associate with Reduced Overall and Progression-Free Survival in Pancreatic Cancer.
Journal: Annals of surgical oncology
Published: April 05, 2023
Pathogenic Variant Spectrum in Breast Cancer Risk Genes in Finnish Patients.
Journal: Cancers
Published: November 08, 2022
Use of self-expandable metallic stents for endoscopic biliary decompression decreases stent complications in pancreatic cancer patients receiving chemotherapy.
Journal: Surgical endoscopy
Published: October 01, 2020
Recurrent moderate-risk mutations in Finnish breast and ovarian cancer patients.
Journal: International journal of cancer
Published: December 11, 2018
Neoadjuvant therapy offers longer survival than upfront surgery for poorly differentiated and higher stage pancreatic cancer.
Journal: Acta oncologica (Stockholm, Sweden)
Published: December 16, 2017
Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility.
Journal: Scientific reports
Published: January 24, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026